226 related articles for article (PubMed ID: 9283100)
1. Whole-body positron emission tomography in clinical oncology: comparison between attenuation-corrected and uncorrected images.
Bengel FM; Ziegler SI; Avril N; Weber W; Laubenbacher C; Schwaiger M
Eur J Nucl Med; 1997 Sep; 24(9):1091-8. PubMed ID: 9283100
[TBL] [Abstract][Full Text] [Related]
2. Attenuation correction in whole-body FDG oncological studies: the role of statistical reconstruction.
Lonneux M; Borbath I; Bol A; Coppens A; Sibomana M; Bausart R; Defrise M; Pauwels S; Michel C
Eur J Nucl Med; 1999 Jun; 26(6):591-8. PubMed ID: 10369944
[TBL] [Abstract][Full Text] [Related]
3. Lesion-to-background ratio in nonattenuation-corrected whole-body FDG PET images.
Imran MB; Kubota K; Yamada S; Fukuda H; Yamada K; Fujiwara T; Itoh M
J Nucl Med; 1998 Jul; 39(7):1219-23. PubMed ID: 9669398
[TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. PET/CT: comparison of quantitative tracer uptake between germanium and CT transmission attenuation-corrected images.
Nakamoto Y; Osman M; Cohade C; Marshall LT; Links JM; Kohlmyer S; Wahl RL
J Nucl Med; 2002 Sep; 43(9):1137-43. PubMed ID: 12215550
[TBL] [Abstract][Full Text] [Related]
6. Role of attenuation correction for fluorine-18 fluorodeoxyglucose positron emission tomography in the primary staging of malignant lymphoma.
Kotzerke J; Guhlmann A; Moog F; Frickhofen N; Reske SN
Eur J Nucl Med; 1999 Jan; 26(1):31-8. PubMed ID: 9933659
[TBL] [Abstract][Full Text] [Related]
7. FDG imaging of lung nodules: a phantom study comparing SPECT, camera-based PET, and dedicated PET.
Coleman RE; Laymon CM; Turkington TG
Radiology; 1999 Mar; 210(3):823-8. PubMed ID: 10207487
[TBL] [Abstract][Full Text] [Related]
8. Optimal dose of 18F-FDG required for whole-body PET using an LSO PET camera.
Everaert H; Vanhove C; Lahoutte T; Muylle K; Caveliers V; Bossuyt A; Franken PR
Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1615-9. PubMed ID: 14504831
[TBL] [Abstract][Full Text] [Related]
9. CT-based attenuation correction in the calculation of semi-quantitative indices of [18F]FDG uptake in PET.
Visvikis D; Costa DC; Croasdale I; Lonn AH; Bomanji J; Gacinovic S; Ell PJ
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):344-53. PubMed ID: 12634961
[TBL] [Abstract][Full Text] [Related]
10. Dual-head gamma camera 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography in oncological patients: effects of non-uniform attenuation correction on lesion detection.
Zimny M; Kaiser HJ; Cremerius U; Reinartz P; Schreckenberger M; Sabri O; Buell U
Eur J Nucl Med; 1999 Aug; 26(8):818-23. PubMed ID: 10436193
[TBL] [Abstract][Full Text] [Related]
11. Capabilities of two- and three-dimensional FDG-PET for detecting small lesions and lymph nodes in the upper torso: a dynamic phantom study.
Raylman RR; Kison PV; Wahl RL
Eur J Nucl Med; 1999 Jan; 26(1):39-45. PubMed ID: 9933660
[TBL] [Abstract][Full Text] [Related]
12. [Cancer detection with whole-body FDG PET images without attenuation correction].
Yasuda S; Ide M; Takagi S; Shohtsu A; Mitomi T; Kobayashi S; Suzuki Y
Kaku Igaku; 1996 Apr; 33(4):367-73. PubMed ID: 8683875
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of a short acquisition protocol for whole-body positron emission tomography with fluorine-18 fluorodeoxyglucose.
Paul AK; Tatsumi M; Fujino K; Hashikawa K; Nishimura T
Eur J Nucl Med; 2001 Nov; 28(11):1697-701. PubMed ID: 11702113
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of myocardial viability by dual-head coincidence gamma camera fluorine-18 fluorodeoxyglucose positron emission tomography with and without non-uniform attenuation correction.
Nowak B; Zimny M; Schwarz ER; Kaiser HJ; Schaefer W; Reinartz P; vom Dahl J; Buell U
Eur J Nucl Med; 2000 Oct; 27(10):1501-8. PubMed ID: 11083539
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of different image reconstruction parameters for interpretation of whole-body PET studies in cancer patients.
Schöder H; Erdi YE; Chao K; Gonen M; Larson SM; Yeung HW
J Nucl Med; 2004 Apr; 45(4):559-66. PubMed ID: 15073250
[TBL] [Abstract][Full Text] [Related]
16. Comparison of fluorine-18 and bromine-76 imaging in positron emission tomography.
Ribeiro MJ; Almeida P; Strul D; Ferreira N; Loc'h C; Brulon V; Trébossen R; Mazière B; Bendriem B
Eur J Nucl Med; 1999 Jul; 26(7):758-66. PubMed ID: 10398824
[TBL] [Abstract][Full Text] [Related]
17. PET-CT evaluation of 2-deoxy-2-[18F]fluoro-D-glucose myocardial uptake: effect of respiratory motion.
Chin BB; Nakamoto Y; Kraitchman DL; Marshall L; Wahl R
Mol Imaging Biol; 2003; 5(2):57-64. PubMed ID: 14499145
[TBL] [Abstract][Full Text] [Related]
18. Whole-body positron emission tomography: Part I. Methods and performance characteristics.
Dahlbom M; Hoffman EJ; Hoh CK; Schiepers C; Rosenqvist G; Hawkins RA; Phelps ME
J Nucl Med; 1992 Jun; 33(6):1191-9. PubMed ID: 1597738
[TBL] [Abstract][Full Text] [Related]
19. An analytic study of the effects of attenuation on tumor detection in whole-body PET oncology imaging.
Bai C; Kinahan PE; Brasse D; Comtat C; Townsend DW; Meltzer CC; Villemagne V; Charron M; Defrise M
J Nucl Med; 2003 Nov; 44(11):1855-61. PubMed ID: 14602870
[TBL] [Abstract][Full Text] [Related]
20. [Influence of single-photon emission scan duration measured with the ECAT ART PET scanner].
Schaefer A; Kremp S; Hellwig D; Alexander C; Kirsch CM
Nuklearmedizin; 2000 Sep; 39(6):156-65. PubMed ID: 11057407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
